Havix Group Inc. d/b/a Aavis Pharmaceuticals

Senores Pharmaceuticals seeks shareholder approval via postal ballot for eight resolutions including material related party transactions. Proposed RPTs with subsidiaries total ₹754 crore for FY27 and